Franklin Resources’s Emergent Biosolutions EBS Stock Holding History

Franklin Resources’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.34M	Buy	161,943 +82,998	+105%	+$860K	﹤0.01%	2071
2025 Q4	$976K	Buy	78,945 +1,764	+2%	+$18.9K	﹤0.01%	2092
2025 Q3	$681K	Buy	+77,181	New	+$600K	﹤0.01%	2292
2021 Q4	–	Sell	-4,227	Closed	-$212K	–	2493
2021 Q3	$212K	Sell	4,227 -73,852	-95%	-$4.47M	﹤0.01%	2220
2021 Q2	$4.92M	Sell	78,079 -364,883	-82%	-$23.4M	﹤0.01%	1142
2021 Q1	$41.2M	Buy	442,962 +2,845	+0.6%	+$291K	0.02%	670
2020 Q4	$39.4M	Buy	440,117 +32,561	+8%	+$2.99M	0.02%	655
2020 Q3	$42.1M	Buy	407,556 +467	+0.1%	+$50.3K	0.02%	597
2020 Q2	$38.3M	Sell	407,089 -884	-0.2%	-$65.9K	0.02%	598
2020 Q1	$23.6M	Sell	407,973 -21,558	-5%	-$1.24M	0.02%	636
2019 Q4	$23.2M	Sell	429,531 -695	-0.2%	-$37.7K	0.01%	726
2019 Q3	$22.5M	Buy	430,226 +40,692	+10%	+$1.9M	0.01%	715
2019 Q2	$18.8M	Buy	389,534 +182,197	+88%	+$8.73M	0.01%	760
2019 Q1	$10.5M	Buy	+207,337	New	+$12.2M	0.01%	864

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Franklin Resources's EBS Position: Q1 2026 in Review

Franklin Resources increased its Emergent Biosolutions (EBS) stake by 105% in Q1 2026, buying an estimated $860K and bringing the position to 161,943 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2071.

Franklin Resources first reported a position in EBS in Q1 2019 and has held it in 14 quarters since. The position peaked at $42.1M in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

Franklin Resources held 161,943 shares of Emergent Biosolutions worth $1.34M as of Q1 2026.
Franklin Resources bought 82,998 Emergent Biosolutions shares in Q1 2026, an estimated $860K.
Emergent Biosolutions made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #2071 holding.
Franklin Resources first reported a position in Emergent Biosolutions in Q1 2019 and has held it in 14 quarters since.
Franklin Resources's Emergent Biosolutions position peaked at $42.1M in Q3 2020.
190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.